Novartis AG Common Stock (NVS)

Financing Cash Flow

-$2.03B

Quarterly · Period ending: · USD

NVS logo

NVS Financing Cash Flow

Latest reported-$2.03B
NVS Quarterly Cash from Financing (-$5.85B → -$2.03B)
High-resolution chart · PNG

NVS financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-2,030,879,325
3,579,000,000
1,713,081,719
-2,789,000,000
-5,213,000,000
-8,548,000,000
-2,996,000,000
-382,000,000
-3,200,000,000
-5,164,000,000
-607,000,000
-832,000,000
-3,637,000,000
-9,202,000,000
-3,994,000,000
-4,738,000,000
-2,302,000,000
-9,528,000,000
-3,251,000,000
-1,534,000,000
-2,939,000,000
-8,540,000,000
-2,936,000,000
1,900,000,000
-2,185,000,000
1,013,000,000
-1,203,000,000
-2,713,000,000
-28,000,000
-9,683,000,000
453,000,000
-1,621,000,000
-1,530,000,000
-1,546,000,000
-2,396,000,000
-1,937,000,000
-3,012,000,000
-388,000,000
-2,303,000,000
-342,000,000
-1,642,000,000
-1,027,000,000
-2,775,000,000
-2,196,000,000
-2,450,000,000
-1,755,000,000
-742,000,000
-1,080,000,000
-2,638,000,000
-3,687,000,000
-1,518,000,000
-1,392,000,000
-2,519,000,000
-3,340,000,000
-1,144,000,000
-2,117,000,000
-1,672,000,000
-1,742,000,000
-4,220,000,000
-3,760,000,000
-6,557,000,000
-487,000,000
-4,060,000,000
7,204,000,000
950,000,000
22,000,000
-141,000,000
443,000,000
2,055,000,000
452,000,000
-3,748,000,000
685,000,000
4,179,000,000
-3,689,000,000
-3,156,000,000
-2,873,000,000
-807,000,000
-2,482,000,000
-1,938,000,000
-462,000,000
-823,000,000
-1,747,000,000
1,801,000,000
-597,000,000
1,646,000,000
-3,116,000,000
820,000,000
-952,000,000
-740,000,000
-2,252,000,000
-588,000,000
-879,000,000
-2,590,000,000
-1,707,000,000
822,000,000
-5,846,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.